Why are nurses important in the patient journey?
From the bench to bedside: AML treatment
The IFM 2012-03 trial: what will the next step be?
The role of the Worldwide Network for Blood & Marrow Transplantation (WBMT)
What’s new in minimal residual disease (MRD) detection in myeloma?